ObsEva appoints Annette Clancy as Chair of its Board of Directors

– SWITZERLAND, Geneva –  ObsEva SA ( SIX: OBSN | NASDAQ: OBSV), a biopharmaceutical company developing and commercializing novel therapies for women’s health, today announced the appointment of Annette Clancy as Chair of the Board of Directors on May 18, 2022, succeeding Dr.…